Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenalisib in Advanced or Metastatic Breast Cancer
NCT05021900Phase 2Completed
- Sponsor
- Rhizen Pharmaceuticals AG
- Start
- Oct 2021
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tenalisib in breast cancer, sponsored by Rhizen Pharmaceuticals AG. Started Oct 2021; status: completed.
02
Drugs
tenalisib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05021900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05021900.